Lantheus Holdings, Inc. Revenue
Lantheus Holdings, Inc. (LNTH) reported Revenue of $388.18 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-06
- Lantheus Holdings, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $388.18M, a 2.68% increase year-over-year.
- Lantheus Holdings, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $377.33M, a 1.23% increase year-over-year.
- Lantheus Holdings, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $406.79M, a 4.01% increase year-over-year.
- Lantheus Holdings, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $384.01M, a 1.39% increase year-over-year.
- Lantheus Holdings, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $1.54B, a 0.50% increase from fiscal 2024.
- Lantheus Holdings, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $1.53B, a 18.32% increase from fiscal 2023.
- Lantheus Holdings, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $1.30B, a 38.65% increase from fiscal 2022.
- Lantheus Holdings, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $935.06M, a 119.91% increase from fiscal 2021.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $388.18M 10-Q · filed 2026-08-06 | $765.51M 10-Q · filed 2026-08-06 | $1.17B derived: sum of 3 quarters · filed 2026-08-06 | $1.56B derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $377.33M 10-Q · filed 2026-05-07 | $784.12M derived: sum of 2 quarters · filed 2026-05-07 | $1.17B derived: sum of 3 quarters · filed 2026-05-07 | $1.55B derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $406.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $790.80M derived: sum of 2 quarters · filed 2026-02-26 | $1.17B derived: sum of 3 quarters · filed 2026-08-06 | $1.54B 10-K · filed 2026-02-26 |
| 2025-09-30 | $384.01M 10-Q · filed 2025-11-06 | $762.06M derived: sum of 2 quarters · filed 2026-08-06 | $1.13B 10-Q · filed 2025-11-06 | $1.53B derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $378.05M 10-Q · filed 2026-08-06 | $750.81M 10-Q · filed 2026-08-06 | $1.14B derived: sum of 3 quarters · filed 2026-08-06 | $1.52B derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $372.76M 10-Q · filed 2026-05-07 | $763.87M derived: sum of 2 quarters · filed 2026-05-07 | $1.14B derived: sum of 3 quarters · filed 2026-05-07 | $1.54B derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $391.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $769.84M derived: sum of 2 quarters · filed 2026-02-26 | $1.16B derived: sum of 3 quarters · filed 2026-02-26 | $1.53B 10-K · filed 2026-02-26 |
| 2024-09-30 | $378.73M 10-Q · filed 2025-11-06 | $772.83M derived: sum of 2 quarters · filed 2025-11-06 | $1.14B 10-Q · filed 2025-11-06 | $1.50B derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $394.09M 10-Q · filed 2025-08-06 | $764.07M 10-Q · filed 2025-08-06 | $1.12B derived: sum of 3 quarters · filed 2026-02-26 | $1.44B derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $369.98M 10-Q · filed 2025-05-07 | $723.97M derived: sum of 2 quarters · filed 2026-02-26 | $1.04B derived: sum of 3 quarters · filed 2026-02-26 | $1.37B derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $354.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $673.95M derived: sum of 2 quarters · filed 2026-02-26 | $995.64M derived: sum of 3 quarters · filed 2026-02-26 | $1.30B 10-K · filed 2026-02-26 |
| 2023-09-30 | $319.95M 10-Q · filed 2024-11-06 | $641.65M derived: sum of 2 quarters · filed 2024-11-06 | $942.43M 10-Q · filed 2024-11-06 | $1.21B derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $321.70M 10-Q · filed 2024-07-31 | $622.48M 10-Q · filed 2024-07-31 | $885.65M derived: sum of 3 quarters · filed 2025-02-26 | $1.12B derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $300.78M 10-Q · filed 2024-05-02 | $563.95M derived: sum of 2 quarters · filed 2025-02-26 | $803.24M derived: sum of 3 quarters · filed 2025-02-26 | $1.03B derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | $263.17M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $502.46M derived: sum of 2 quarters · filed 2025-02-26 | $726.18M derived: sum of 3 quarters · filed 2025-02-26 | $935.06M 10-K · filed 2025-02-26 |
| 2022-09-30 | $239.29M 10-Q · filed 2023-11-02 | $463.01M derived: sum of 2 quarters · filed 2023-11-02 | $671.89M 10-Q · filed 2023-11-02 | $801.46M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $223.72M 10-Q · filed 2023-08-03 | $432.60M 10-Q · filed 2023-08-03 | $562.16M derived: sum of 3 quarters · filed 2024-02-22 | $664.24M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $208.88M 10-Q · filed 2023-05-04 | $338.44M derived: sum of 2 quarters · filed 2024-02-22 | $440.51M derived: sum of 3 quarters · filed 2024-02-22 | $541.58M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $129.56M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $231.63M derived: sum of 2 quarters · filed 2024-02-22 | $332.70M derived: sum of 3 quarters · filed 2024-02-22 | $425.21M 10-K · filed 2024-02-22 |
| 2021-09-30 | $102.07M 10-Q · filed 2022-11-03 | $203.14M derived: sum of 2 quarters · filed 2022-11-03 | $295.65M 10-Q · filed 2022-11-03 | $389.80M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $101.06M 10-Q · filed 2022-08-04 | $193.57M 10-Q · filed 2022-08-04 | $287.73M derived: sum of 3 quarters · filed 2023-02-23 | $376.27M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $92.51M 10-Q · filed 2022-04-29 | $186.66M derived: sum of 2 quarters · filed 2023-02-23 | $275.20M derived: sum of 3 quarters · filed 2023-02-23 | $341.21M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $94.15M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $182.70M derived: sum of 2 quarters · filed 2023-02-23 | $248.71M derived: sum of 3 quarters · filed 2023-02-23 | $339.41M 10-K · filed 2023-02-23 |
| 2020-09-30 | $88.54M 10-Q · filed 2021-11-04 | $154.55M derived: sum of 2 quarters · filed 2021-11-04 | $245.26M 10-Q · filed 2021-11-04 | $334.60M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $66.01M 10-Q · filed 2021-07-28 | $156.71M 10-Q · filed 2021-07-28 | $246.06M derived: sum of 3 quarters · filed 2021-07-28 | $331.84M derived: sum of 4 quarters · filed 2021-07-28 |
| 2020-03-31 | $90.70M 10-Q · filed 2021-05-04 | $180.05M derived: sum of 2 quarters · filed 2021-05-04 | $265.83M derived: sum of 3 quarters · filed 2021-05-04 | $351.53M derived: sum of 4 quarters · filed 2021-05-04 |
| 2019-12-31 | $89.35M 10-K · filed 2020-02-25 | $175.12M derived: sum of 2 quarters · filed 2020-11-05 | $260.83M derived: sum of 3 quarters · filed 2020-11-05 | $347.34M 10-K · filed 2022-02-24 |
| 2019-09-30 | $85.78M 10-Q · filed 2020-11-05 | $171.48M derived: sum of 2 quarters · filed 2020-11-05 | $257.99M 10-Q · filed 2020-11-05 | $344.26M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $85.70M 10-Q · filed 2020-07-31 | $172.22M 10-Q · filed 2020-07-31 | $258.49M derived: sum of 3 quarters · filed 2020-07-31 | $347.39M derived: sum of 4 quarters · filed 2020-07-31 |
| 2019-03-31 | $86.51M 10-Q · filed 2020-04-30 | $172.78M derived: sum of 2 quarters · filed 2020-04-30 | $261.68M derived: sum of 3 quarters · filed 2020-04-30 | $347.25M derived: sum of 4 quarters · filed 2020-04-30 |
| 2018-12-31 | $86.27M 10-K · filed 2020-02-25 | $175.17M derived: sum of 2 quarters · filed 2020-02-25 | $260.74M derived: sum of 3 quarters · filed 2020-02-25 | $343.37M 10-K · filed 2021-02-25 |
| 2018-09-30 | $88.90M 10-K · filed 2020-02-25 | $174.47M derived: sum of 2 quarters · filed 2020-02-25 | $257.10M 10-Q · filed 2019-10-31 | $338.34M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $85.57M 10-K · filed 2020-02-25 | $168.20M 10-Q · filed 2019-07-25 | $249.44M derived: sum of 3 quarters · filed 2020-02-25 | $329.38M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $82.63M 10-K · filed 2020-02-25 | $163.87M derived: sum of 2 quarters · filed 2020-02-25 | $243.81M derived: sum of 3 quarters · filed 2020-02-25 | $332.65M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $81.24M 10-K · filed 2019-02-20 | $161.18M derived: sum of 2 quarters · filed 2019-02-20 | $250.02M derived: sum of 3 quarters · filed 2019-02-20 | $331.38M 10-K · filed 2020-02-25 |
| 2017-09-30 | $79.94M 10-K · filed 2019-02-20 | $168.78M derived: sum of 2 quarters · filed 2019-02-20 | $250.14M 10-Q · filed 2018-10-30 | |
| 2017-06-30 | $88.84M 10-K · filed 2019-02-20 | $170.20M 10-Q · filed 2018-08-01 | ||
| 2017-03-31 | $81.36M 10-K · filed 2019-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |